about
Neuronal nitric oxide synthase and calbindin delineate sex differences in the developing hypothalamus and preoptic area.CBF changes associated with focal ischemic preconditioning in the spontaneously hypertensive rat.Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes.Neuroprotective effect of volatile anesthetic agents: molecular mechanisms.Qingkailing Suppresses the Activation of BV2 Microglial Cells by Inhibiting Hypoxia/Reoxygenation-Induced Inflammatory Responses.Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotectionNMDA-induced neuronal survival is mediated through nuclear factor I-A in miceEndoplasmic reticulum refilling and mitochondrial calcium extrusion promoted in neurons by NCX1 and NCX3 in ischemic preconditioning are determinant for neuroprotection.Role of morphine preconditioning and nitric oxide following brain ischemia reperfusion injury in mice.Inhalational anesthetics as preconditioning agents in ischemic brain.Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brainBeyond anoxia: the physiology of metabolic downregulation and recovery in the anoxia-tolerant turtle.Molecular physiology of preconditioning-induced brain tolerance to ischemia.Inositol 1,4,5-triphosphate receptors and NAD(P)H mediate Ca2+ signaling required for hypoxic preconditioning of hippocampal neurons.Ischemic tolerance as an active and intrinsic neuroprotective mechanism.Post-ischemic brain damage: effect of ischemic preconditioning and postconditioning and identification of potential candidates for stroke therapy.Pleiotropic effects of acarbose on atherosclerosis development in rabbits are mediated via upregulating AMPK signals.Protein modifications involved in neurotransmitter and gasotransmitter signaling.Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.Isoflurane provides neuroprotection in neonatal hypoxic ischemic brain injuryNovel Cellular Mechanisms for Neuroprotection in Ischemic Preconditioning: A View from Inside Organelles.Hyperbaric oxygen therapy of spinal cord injury.Mediterranean diet and inflammaging within the hormesis paradigm.Regulation of endothelial nitric oxide synthase by agmatine after transient global cerebral ischemia in rat brain.(S)-ZJM-289 preconditioning induces a late phase protection against nervous injury induced by transient cerebral ischemia and oxygen-glucose deprivation.Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats.Hormesis and disease resistance: activation of cellular stress response pathways.Loss of hippocampal neuronal nitric oxide synthase contributes to the stress-related deficit in learning and memory.Long-lasting neuroprotective effect of sildenafil against 3,4-methylenedioxymethamphetamine- induced 5-hydroxytryptamine deficits in the rat brain.Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation.NO-induced neuroprotection in ischemic preconditioning stimulates mitochondrial Mn-SOD activity and expression via RAS/ERK1/2 pathway
P2860
Q30420008-BBA15506-9065-454B-ADC6-B21F0BE7C933Q33231450-0C99A2C6-53CE-4C15-BA10-12E3AE4BF9D8Q33302694-04CCB585-96A2-444F-8459-425AD4ED5B49Q33419745-8F8614CC-ADB6-458C-8183-500E60FD647AQ33608619-201E94CB-2C36-486D-A227-C28C3B168E53Q33694824-9707E447-030B-4A2C-8A23-4D221E24F39FQ33967981-9C441609-6476-4388-8D94-351E82048F9CQ34393800-BD7F25E7-0B9C-41AC-B03A-DD1044456A5CQ35197827-21EE7D55-89E0-4C9D-851F-6C0E03660EFDQ36478937-7C2B89EB-FC8F-45E1-88AC-987338239870Q36493856-46650FEB-4687-47D0-A36D-D4E378A666CCQ36627668-320CC481-E85D-4B38-8608-58DDBBF48966Q37056974-E7E1706F-2A12-4475-B8B2-492BB16F3C3BQ37198131-38E9B11C-9A7D-4F94-BD06-5E1527080026Q37268106-0C55570A-D7C8-4A2C-9589-C1DDE045EC5AQ37352186-1556B9B8-647B-437B-8935-3B8319B4F18DQ37480157-B9BC422D-941E-4DAF-AFB7-F386985824B4Q37789075-1DA5301B-A2CB-4B52-8772-F93BBD038A26Q37971308-5E759C37-C4B1-48EC-A394-963F4EBA1A10Q38123960-A5E9FB82-AE60-4B49-B865-17F7D30A7D06Q38527790-DDE90C45-B222-4AE9-89D7-E2B4F46CC2AFQ38651796-1B464BC8-7295-4D46-A8E7-927BA882A309Q38736064-1FC85F0A-D0DF-4C7B-9550-7AA09156D3A2Q41613531-51E71FD4-B048-4A78-B521-BFBAE4755C24Q44197207-CADB06C1-0520-46CF-A81D-59E9298BC3C0Q46205659-6873B3DC-7443-4237-9D72-A46230AAB06FQ46595800-0508C3EA-318B-46A4-8BA5-BA6A587F4785Q48210888-3852AF85-2213-444C-A6AD-5C7B262757D8Q48878720-DCA368B3-9631-44E3-9F6A-E1E355A5F2F1Q55043421-DE0E2C1E-E6A9-4F4E-9B03-B428F66B085AQ59265517-4B58EAB6-1D64-49EC-BC17-D119F124796C
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Nitric oxide and cerebral ischemic preconditioning.
@ast
Nitric oxide and cerebral ischemic preconditioning.
@en
type
label
Nitric oxide and cerebral ischemic preconditioning.
@ast
Nitric oxide and cerebral ischemic preconditioning.
@en
prefLabel
Nitric oxide and cerebral ischemic preconditioning.
@ast
Nitric oxide and cerebral ischemic preconditioning.
@en
P1433
P1476
Nitric oxide and cerebral ischemic preconditioning
@en
P2093
Paul L Huang
P304
P356
10.1016/J.CECA.2004.02.007
P50
P577
2004-09-01T00:00:00Z